Varian (NYSE: VAR) announced it has successfully completed its asset purchase of the Boston Scientific portfolio of microsphere and bland embolic bead products for treating arteriovenous malformations and hypervascular tumors. This acquisition expands the portfolio of Varian interventional oncology solutions.
Date: August 26, 2019
Source: Varian